MGVS LTD has a total of 25 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are MODEX THERAPEUTIQUES S A, SELECTIVE GENETICS INC and CYTOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | Israel | 3 | |
#5 | Australia | 2 | |
#6 | Czechia | 2 | |
#7 | Poland | 2 | |
#8 | United States | 2 | |
#9 | South Africa | 2 | |
#10 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Object sterilising | |
#6 | Implantable devices | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Flugelman Moshe Y | 21 |
#2 | Preis Meir | 20 |
#3 | Koren Belly | 20 |
#4 | Cohen Tzafra | 20 |
#5 | Gluzman Zoya | 20 |
#6 | Weisz Anat | 16 |
#7 | Tsaba Adili | 12 |
#8 | Ott Michael | 5 |
#9 | Flugelman Moshe Z | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016092542A1 | Use of fibulin-5 for the treatment of keloid scars | |
WO0212539A2 | Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis | |
US2002164310A1 | Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension | |
HU0300810A2 | Artifical vascular grafts, and methods of producing and using same |